Jack Hsiao
Directeur/Membre du Conseil chez APPLIED BIOCODE CORPORATION
Postes actifs de Jack Hsiao
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| APPLIED BIOCODE CORPORATION | Directeur/Membre du Conseil | 03/01/2018 | - |
| Independent Dir/Board Member | 03/01/2018 | - | |
Applied BioCode, Inc.
 Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022. | Directeur/Membre du Conseil | - | - |
| Independent Dir/Board Member | - | - |
Historique de carrière de Jack Hsiao
Statistiques
Internationale
| Etats-Unis | 2 |
| Taïwan | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
Sectorielle
| Electronic Technology | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| APPLIED BIOCODE CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
Applied BioCode, Inc.
Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022. | Electronic Technology |
- Bourse
- Insiders
- Jack Hsiao
- Expérience
